First quinquennial review of intensity-modulated radiotherapy at St Bartholomew's Hospital, London.
Intensity-modulated radiotherapy (IMRT) is a relatively new technique of delivering external beam radiotherapy that is becoming increasingly available in the UK. This paper summarises the introduction and initial clinical work in IMRT over the period 2004-2009. Physics aspects of commissioning are described, including the development of a robust method of quality control using a sweeping gap test. Details of the organisational changes necessary to introduce IMRT are given. The clinical selection and practice in head and neck sites are described, together with promising early results on the maintenance of salivary flow after IMRT. A summary of research into optimal planning for pelvic cancer follows. The controversial areas of breast and paediatric IMRT are discussed with recommendations on practice. The potential for concomitant boost therapy is exemplified in the treatment of brain metastatic disease.
Smith
D
D
Department of Radiotherapy, St Bartholomew's Hospital, London, UK.
MacDougall
N
N
Monk
J
J
Sibtain
A
A
Powell
M E
ME
Plowman
P N
PN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000532:radiotherapy; D002528:Cerebellar Neoplasms / Q000532:radiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006761:Hospitals; D006801:Humans; D008131:London; D008297:Male; D008527:Medulloblastoma / Q000532:radiotherapy; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000532:radiotherapy; D017410:Practice Guidelines as Topic; D011786:Quality Control; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods / Q000592:standards; D012208:Rhabdomyosarcoma / Q000532:radiotherapy